Search Results - "Sebagh M"

A proposed new method for assessing the pathological response to chemotherapy in resected colorectal liver metastases.

Authors: Sebagh, M Allard, M-A Cunha, A S et al.

Source: British Journal of Cancer. 7/29/2014, Vol. 111 Issue 3, p470-476. 7p. 1 Diagram, 2 Charts, 2 Graphs.

A 10 year follow up study of patients transplanted for autoimmune hepatitis: histological recurrence precedes clinical and biochemical recurrence.

Authors: Sebagh, M. Rifai, K. Johanet, C. et al.

Source: Gut (0017-5749). Jun2003, Vol. 52 Issue 6, p893-897. 6p. 1 Color Photograph, 7 Charts.

Hepatocellular carcinoma with lymphoid stroma: a tumour with good prognosis after liver transplantation.

Authors: Emile, J-F Adam, R Sebagh, M et al.

Source: Histopathology. Dec2000, Vol. 37 Issue 6, p523-529. 7p. 4 Black and White Photographs, 1 Chart, 1 Graph.

Liver resection for transplantable HCC on chronic liver disease: patterns of recurrence and implications for treatment choice.

Authors: Gelli, M. Sebagh, M. Romanelli, E. et al.

Source: HPB (1365-182X). Sep2018 Supplement 2, Vol. 20, pS262-S262. 1p.

976 CENTRILOBULAR CHANGES ARE KEY HISTOLOGICAL FINDINGS FOR SEGREGATING CASES OF DE NOVO AUTOIMMUNE HEPATITIS AFTER LIVER TRANSPLANTATION

Authors: Sebagh, M. Coilly, A. Castillo-Rama, M. et al.

Source: Journal of Hepatology. Apr2012 Supplement, Vol. 56 Issue s2, pS381-S382. 0p.

221 20-YEAR PROTOCOL LIVER BIOPSIES: INVASIVE BUT USEFUL FOR THE MANAGEMENT OF LIVER RECIPIENTS

Authors: Sebagh, M. Samuel, D. Antonini, T.M. et al.

Source: Journal of Hepatology. Apr2012 Supplement, Vol. 56 Issue s2, pS93-S94. 0p.

464 CHARACTERISTICS AND PROGNOSIS OF FIBROSING CHOLESTATIC HEPATITIS AFTER LIVER TRANPLANTATION IN A LARGE COHORT OF HIV/HCV CO-INFECTED PATIENTS

Authors: Antonini, T.M. Sebagh, M. Roque-Afonso, A.-M. et al.

Source: Journal of Hepatology. Apr2010 Supplement 1, Vol. 52, pS188-S188. 1p.

233 EFFECT OF ANTIVIRAL TREATMENT, RETREATMENT, AND STAGE OF FIBROSIS ON PROGRESSION OF LIVER FIBROSIS, AND OUTCOME AFTER LIVER TRANSPLANTATION

Authors: Roche, B. Sebagh, M. Acanfora, A.M. et al.

Source: Journal of Hepatology. May2008 Supplement 2, Vol. 48, pS95-S96. 0p.

158 Donor age and graft histology ten years after liver transplantation

Authors: Rifai, K. Sebagh, M. Karam, V. et al.

Source: Journal of Hepatology. May2004 Supplement 1, Vol. 40, p53. 1p.

Impact of bevacizumab on functional recovery and histology of the liver after resection of colorectal metastases.

Authors: Wicherts, D. A. De Haas, R. J. Sebagh, M. et al.

Source: British Journal of Surgery. Mar2011, Vol. 98 Issue 3, p399-407. 9p. 1 Diagram, 4 Charts, 2 Graphs.

Surgical resection versus systemic therapy for breast cancer liver metastases: Results of a European case matched comparison.

Authors: Ruiz, A. van Hillegersberg, R. Siesling, S. et al.

Source: European Journal of Cancer. May2018, Vol. 95, p1-10. 10p.

140 Influence of graft histologic lesions on recipient quality of life 10 years after liver transplantation

Authors: Karam, V.H. Feray, C. Sebagh, M. et al.

Source: Journal of Hepatology. May2004 Supplement 1, Vol. 40, p48. 2p.

Pilot study of treatment with pegylated interferon and ribavirin in liver transplant recipients with hepatitis C infection

Authors: Roche, B. Roque-Afonso, A.M. Sebagh, M. et al.

Source: Journal of Hepatology. Apr2003 Supplement 2, Vol. 38, p48. 2p.

Very prolonged liposomal amphotericin B use leading to a lysosomal storage disease.

Authors: Michot, J.M. Gubavu, C. Fourn, E. et al.

Source: International Journal of Antimicrobial Agents. Jun2014, Vol. 43 Issue 6, p566-569. 4p.

443 PROGNOSIS OF SEVERE RECURRENCE OF HCV INFECTION AFTER LIVER TRANSPLANTATION IN A LARGE COHORT OF HIV INFECTED PATIENTS

Authors: Antonini, T.M. Roque-Afonso, A.-M. Sebagh, M. et al.

Source: Journal of Hepatology. Apr2009 Supplement 1, Vol. 50, pS168-S168. 1p.

Evaluation of a portable micro-spectrometer for the real-time assessment of liver graft macrosteatosis: algorithm and validation.

Authors: Golse, N. Cosse, C. Laurenzi, A. et al.

Source: HPB (1365-182X). Sep2018 Supplement 2, Vol. 20, pS788-S789. 2p.

Autoimmune liver disease as the main cause of cryptogenic cirrhosis in European patients who underwent liver transplantation

Authors: Barbet, F. Yilmaz Duclos-Vallee, J.C. Johanet, C. et al.

Source: Journal of Hepatology. Apr2003 Supplement 2, Vol. 38, p209. 2p.

P1107 : Unconsidered misuse of acetaminophen is one of the causal cofactors of acute liver failure in adults with severe dengue fever.

Authors: Gelu-Simeon, M. Francoz, C. Ichai, P. et al.

Source: Journal of Hepatology. Apr2015 Supplement 2, Vol. 62, pS765-S765. 1p.

P694 HEPATITIS E INFECTION IN PATIENTS WITH SEVERE ACUTE ALCOHOLIC HEPATITIS.

Authors: Haim-Boukobza, S. Coilly, A. Bouamoud, M. et al.

Source: Journal of Hepatology. Apr2014 Supplement, Vol. 60, pS300-S300. 1p.

P1237 ANTI-HEPATITIS C (HCV) TRIPLE THERAPY WITH PROTEASE INHIBITORS IN HIV/HCV CO-INFECTED PATIENTS AFTER LIVER TRANSPLANTATION.

Authors: Antonini, T.M. Furlan, V. Teicher, E. et al.

Source: Journal of Hepatology. Apr2014 Supplement, Vol. 60, pS501-S501. 1p.